Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00834327
Recruitment Status : Terminated (Neurogen acquired by Ligand Pharmaceuticals - no further support for the study. No safety concerns identified.)
First Posted : February 3, 2009
Last Update Posted : October 14, 2009
Information provided by:
Neurogen Corporation

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : November 2009
  Estimated Study Completion Date : December 2009